兩家獨立企業由此誕生
生命科學與診斷 & 分析和企業服務
DELFIA® Toolbox kits allow you to build your own DELFIA time-resolved fluorescence (TRF) assay using your preferred antibody against the analyte of interest. Painlessly switch your traditional ELISA to one with a wider dynamic range, higher sensitivity, and great signal stability. This kit contains all necessary reagents to perform a sandwiching immunoassay using DELFIA Europium-labeled streptavidin for detection.
false falseFor research use only; not for diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption & disposal requirements under European REACH regulations (EC 1907/2006).
Build your own assay for quantitative detection of target analyte in cell lysate, cell supernatant, tissue extract, serum, plasma, blood, and other sample types using DELFIA time-resolved fluorescence wash-based technology. DELFIA (Dissociation-enhanced lanthanide fluorescence immunoassay) TRF (time-resolved fluorescence) technology is a highly-sensitive wash-based immunoassay platform which utilizes a lanthanide chelate to reduce background and improve assay dynamic range. DELFIA offers significant advantages over traditional ELISA, while keeping a similar workflow:
DELFIA Toolbox Kits allow you to build your own DELFIA assay using your preferred antibody against the analyte of interest, bringing you the ability to painlessly switch your traditional ELISA to one with a wider dynamic range, higher sensitivity and great signal stability. These kits contain:
| 檢測技術 | Time-Resolved Fluorescence (TRF), DELFIA TRF |
|---|---|
| 檢測方法 | Time-Resolved Fluorescence (TRF), DELFIA TRF |
| 產品品牌名稱 | DELFIA |
| 運輸條件 | 藍冰 |
| 產品尺寸 | 5 Half AreaPlates |
Find out about our range of integrated solutions for drug discovery screening in this e-brochure.
Our screening solutions for high-throughput screening, phenotypic screening and data analysis help to streamline drug discovery workflows in labs across the globe. Our portfolio includes automat ...
Along with the expression of the protein of interest, host cells release additional proteins (Host Cell Proteins, HCPs) into the supernatant which must be removed from drug products because they pose a risk of affecting drug quality, safety and efficacy.
The potential immunogenicity of biol ...
